thyroid hormone-binding proteins

30  relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

3,5,3'-triiodothyronine-binding protein; CTBP aldehyde dehydrogenase, Xenopus; CTBP protein, Xenopus; NADPH/NADP-regulated thyroid hormone-binding protein, p38; T3-binding protein p55; T4-binding protein p55; cytosolic thyroid hormone-binding protein; cytosolic thyroid hormone-binding protein, Xenopus; p38 NADPH-NADP-regulated thyroid hormone-binding protein; pyruvate kinase muscle isozyme; pyruvate kinase, M1 isozyme; thyroid hormone-binding protein; thyroid hormone-binding protein p38, NADPH/NADP-regulated; thyroid hormone-binding protein p55; thyroid hormone-binding protein p58; triiodothyronine-binding protein p55

Bio-Agent Context: Research Results

Related Diseases

1.	Hyperthyroidism 01/01/1983 - "Serum T4 is a good test for hyperthyroidism in patients with normal thyroid hormone-binding protein levels. " 07/01/1981 - "Concentration of serum thyroid hormone binding proteins after 131I treatment of hyperthyroidism." 12/20/1980 - "The estimation is thus indicated in all patients with changes in thyroid hormone binding protein concentration and is of great value in confirming or ruling out the diagnosis of T3-toxicosis, T4-toxicosis and in all cases of "preclinical" or borderline hyperthyroidism." 10/01/1982 - "A negative correlation between serum thyroid hormone binding protein (TBG and TBPA) and free thyroxine was observed in patients with hyperthyroidism. " 07/01/1981 - "Changes in the concentration of thyroid hormone binding proteins should be borne in mind when total thyroid hormone concentrations are used to monitor the progress of patients receiving treatment for hyperthyroidism." Order ALL the reference details at left...
2.	Syndrome 01/01/1995 - "The differential diagnosis of this condition may be difficult because it includes various common and unusual syndromes, including quantitative or qualitative changes in thyroid hormone-binding proteins, circulating antibodies against thyroid hormones, resistance to thyroid hormones, influences from drugs, and acute somatic or psychiatric illness (1). " 03/01/1979 - "Serum concentrations of thyrotropin, thyroid hormones and thyroid hormone-binding proteins during acute and recovery stages of idiopathic respiratory distress syndrome." 01/01/1987 - "We concluded that: the abnormalities in thyroid function tests in patients on long-term dialysis (HD and CAPD) do not express the existence of a true hypothyroidism; a different pathogenesis of the low-T4 syndrome in the CAPD and HD groups may be hypothesized: in the former it could be attributed to a reduction in serum-binding capacity for thyroid hormones, in the latter the relative increase in fT4 percentage despite normal TBG levels suggests either the presence of T4-TBG-binding inhibitor(s), or structural abnormalities of thyroid-hormone-binding proteins." 12/01/2007 - "Endocrine disorders including hypothalamus dysfunction, hypopituitarism, syndrome of inappropriate anti-diuretic hormone secretion, diabetes insipidus, growth hormone disorders, hyperprolactinemia, gonadotropin deficiency, serum thyroid hormone-binding protein abnormalities, hypothyroidism, hyperthyroidism, hypomagnesium, hypocalcemia, hyperparathyroidism, hyperparathyroidism, adrenal dysfunction, gonadal dysfunction, hypertriglyceridemia, hypercholesterolemia, diabetes mellitus, and glycosuria were identified and their association with cancer therapies were outlined. " Order ALL the reference details at left...
3.	Familial Dysalbuminemic Hyperthyroxinemia 10/01/1994 - "Results of thyroid hormone-binding protein tests confirmed the diagnosis of familial dysalbuminemic hyperthyroxinemia. " 12/01/1988 - "To determine whether thyroid hormone-binding proteins in serum, particularly albumin, facilitate the transfer of T4 into human tissues, we studied cellular T4 uptake (CT4) by human liver (Hep G2) cells from medium containing serum from subjects with familial dysalbuminemic hyperthyroxinemia (FDH) and acquired and familial T4-binding globulin (TBG) excess and patients with normal T4-binding to albumin and normal TBG concentrations. " 03/01/1989 - "The validity of FT4 results has been questioned mainly in euthyroid patients with altered concentrations of thyroid hormone-binding proteins, as in nonthyroidal illness, hereditary analbuminemia, familial dysalbuminemic hyperthyroxinemia (FDH), and the presence of iodothyronine-binding antibodies. " Order ALL the reference details at left...
4.	Hypothyroidism 11/21/1987 - "Experimental data are discussed which support the proposal that antagonist binding of PCBs to thyroid hormone binding proteins in serum could produce varying degrees of hypothyroidism. " 01/01/1987 - "We concluded that: the abnormalities in thyroid function tests in patients on long-term dialysis (HD and CAPD) do not express the existence of a true hypothyroidism; a different pathogenesis of the low-T4 syndrome in the CAPD and HD groups may be hypothesized: in the former it could be attributed to a reduction in serum-binding capacity for thyroid hormones, in the latter the relative increase in fT4 percentage despite normal TBG levels suggests either the presence of T4-TBG-binding inhibitor(s), or structural abnormalities of thyroid-hormone-binding proteins." 12/01/2007 - "Endocrine disorders including hypothalamus dysfunction, hypopituitarism, syndrome of inappropriate anti-diuretic hormone secretion, diabetes insipidus, growth hormone disorders, hyperprolactinemia, gonadotropin deficiency, serum thyroid hormone-binding protein abnormalities, hypothyroidism, hyperthyroidism, hypomagnesium, hypocalcemia, hyperparathyroidism, hyperparathyroidism, adrenal dysfunction, gonadal dysfunction, hypertriglyceridemia, hypercholesterolemia, diabetes mellitus, and glycosuria were identified and their association with cancer therapies were outlined. " Order ALL the reference details at left...
5.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/23/1991 - "We have recently shown that the cytosolic thyroid hormone binding protein (p58-M2) in human epidermoid carcinoma A431 cells is a monomer of pyruvate kinase, subtype M2 (PKM2). " 12/02/1986 - "Four mouse hybridoma cell lines have been isolated which secrete antibodies to the membrane-associated thyroid hormone binding protein (Mr 55,000) from human epidermoid carcinoma A431 cells. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Thyroid Hormones
2.	Hormones
3.	Antibodies
4.	Thyroxine (Levothyroxine)
5.	Pyruvate Kinase
6.	Squalene Monooxygenase (Squalene Epoxidase)
7.	Protein Disulfide-Isomerases
8.	Interleukin-6 (Interleukin 6)
9.	Thyrotropin (Thyroid-Stimulating Hormone)
10.	Superoxide Dismutase

Related Therapies and Procedures

1.	Continuous Ambulatory Peritoneal Dialysis (CAPD)